Despite rapidly rising Covid-19 deaths and an approval to use Remdesivir for treatment of severe cases, Indian patients are still waiting for the drug to be available in the country as companies are awaiting marketing approval from the Drugs Controller General of India (DCGI).
from RSSMix.com Mix ID 8289560 https://ift.tt/2BI8yZ0
Sunday, June 7, 2020
Home »
RSSMix.com Mix ID 8289560
» 5 firms await regulator’s nod to make Remdesivir
0 comments:
Post a Comment